Total planned funding: $154,609,393
Allocations
Countries/Regions
India | $154,609,393 |
Organizational Types
NGO | $69,034,855 |
Unknown | $29,442,862 |
Own Agency | $24,150,484 |
University | $21,982,112 |
Private Contractor | $3,348,272 |
Multi-lateral Agency | $2,866,808 |
FBO | $1,400,000 |
Host Country Government Agency | $1,349,400 |
Other USG Agency | $1,034,600 |
Implementing Agency | $0 |
Program Areas
Governance and Systems | $63,113,839 |
Prevention | $35,116,064 |
Care | $20,640,748 |
Management and Operations | $17,593,022 |
Treatment | $7,304,926 |
Testing | $6,413,002 |
Budget Codes
OHSS: Health Systems Strengthening | $38,896,894 |
HVOP: Sexual Prevention: Other Sexual Prevention | $21,666,663 |
HVSI: Strategic Information | $19,253,828 |
HVMS: Management and Operations | $17,593,022 |
HBHC: Care: Adult Care and Support | $12,236,042 |
HTXS: Treatment: Adult Treatment | $6,858,291 |
HVCT: Testing: HIV Testing and Counseling | $6,413,002 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $5,547,855 |
HLAB: Laboratory Infrastructure | $4,963,117 |
HKID: Care: Orphans and Vulnerable Children | $4,173,146 |
HVTB: Care: TB/HIV | $3,478,220 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $3,477,497 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $3,114,396 |
HMBL: Biomedical Prevention: Blood Safety | $1,299,653 |
PDCS: Care: Pediatric Care and Support | $753,340 |
PDTX: Treatment: Pediatric Treatment | $423,158 |
HTXD: Treatment: ARV Drugs | $23,477 |
HMIN: Biomedical Prevention: Injection Safety | $10,000 |
Top Partner Programs
Not Available:
$27,770,884
Countries/Regions
Voluntary Health Services:
$16,240,000
Countries/Regions
FHI 360:
$15,204,825
Countries/Regions
University of Manitoba:
$13,592,112
Countries/Regions
USG Aggregated Agencies:
$10,203,301
Countries/Regions